Mitofusin-2 prevents skeletal muscle wasting in cancer cachexia

  • Authors:
    • Qiu‑Lei Xi
    • Bo Zhang
    • Yi Jiang
    • Hai‑Sheng Zhang
    • Qing‑Yang Meng
    • Ying Chen
    • Yu‑Song Han
    • Qiu‑Lin Zhuang
    • Jun Han
    • Hai‑Yu Wang
    • Jing Fang
    • Guo‑Hao Wu
  • View Affiliations

  • Published online on: September 26, 2016     https://doi.org/10.3892/ol.2016.5191
  • Pages: 4013-4020
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Cancer cachexia remains a leading cause of morbidity and mortality worldwide, despite extensive research and clinical trials. The prominent clinical feature of cancer cachexia is the continuous loss of skeletal muscle that cannot be fully reversed by conventional nutritional support, and that leads to progressive functional impairment. The mechanism underlying muscle loss in patients with cachexia is poorly understood. The present study analyzed 21 cancer patients with or without cachexia, and demonstrated that mitofusin‑2 (Mfn2) was downregulated in the rectus abdominis of patients with cachexia, which was associated with body weight loss. In vitro cell experiments indicated that loss of Mfn2 was associated with atrophy of the C2C12 mouse myoblast cell line. Furthermore, in vivo animal experiments demonstrated that cachexia decreased gastrocnemius muscle mass and Mfn2 expression, and overexpression of Mfn2 in gastrocnemius muscle was able to partially attenuate cachexia‑induced gastrocnemius muscle loss. The results of the present study suggested that Mfn2 is involved in cachexia‑induced muscle loss and may serve as a potential target for therapy of cachexia.
View Figures
View References

Related Articles

Journal Cover

November-2016
Volume 12 Issue 5

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Xi QL, Zhang B, Jiang Y, Zhang HS, Meng QY, Chen Y, Han YS, Zhuang QL, Han J, Wang HY, Wang HY, et al: Mitofusin-2 prevents skeletal muscle wasting in cancer cachexia. Oncol Lett 12: 4013-4020, 2016
APA
Xi, Q., Zhang, B., Jiang, Y., Zhang, H., Meng, Q., Chen, Y. ... Wu, G. (2016). Mitofusin-2 prevents skeletal muscle wasting in cancer cachexia. Oncology Letters, 12, 4013-4020. https://doi.org/10.3892/ol.2016.5191
MLA
Xi, Q., Zhang, B., Jiang, Y., Zhang, H., Meng, Q., Chen, Y., Han, Y., Zhuang, Q., Han, J., Wang, H., Fang, J., Wu, G."Mitofusin-2 prevents skeletal muscle wasting in cancer cachexia". Oncology Letters 12.5 (2016): 4013-4020.
Chicago
Xi, Q., Zhang, B., Jiang, Y., Zhang, H., Meng, Q., Chen, Y., Han, Y., Zhuang, Q., Han, J., Wang, H., Fang, J., Wu, G."Mitofusin-2 prevents skeletal muscle wasting in cancer cachexia". Oncology Letters 12, no. 5 (2016): 4013-4020. https://doi.org/10.3892/ol.2016.5191